ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 2343

$1.27M Total Retail Price of All Prescriptions

Rank: 45 out of 2343

1,433 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,433 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 1,433 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 22,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
CARVEDILOL 1,621 1,300 10 1 27
WARFARIN SODIUM 1,051 885 2 8
LISINOPRIL 985 752 3 3
SIMVASTATIN 889 754 4 1
METOPROLOL TARTRATE 806 676 5 7
LEVOTHYROXINE SODIUM 797 714 6 2
FUROSEMIDE 796 645 7 6
POTASSIUM CHLORIDE 760 613 8 18
OMEPRAZOLE 758 623 9 4
CLOPIDOGREL 721 584 10 26
PRAVASTATIN SODIUM 717 624 11 15
AMLODIPINE BESYLATE 717 614 11 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 548 475 13 42
ATENOLOL 442 392 14 12
PLAVIX 422 360 15 38
METFORMIN HCL 412 311 16 9
GABAPENTIN 338 240 17 16
ATORVASTATIN CALCIUM 336 288 18 10
CITALOPRAM HBR 326 257 19 17
GLIPIZIDE 320 303 20 56
LOSARTAN POTASSIUM 310 275 21 19
HYDROCODONE-ACETAMINOPHEN 287 189 S3 22 13
LOVASTATIN 263 218 23 47
ISOSORBIDE MONONITRATE ER 242 211 24 32
FAMOTIDINE 241 193 25 60
TERAZOSIN HCL 230 201 26 143
SOTALOL 224 198 27 177
METOPROLOL SUCCINATE 222 188 28 14
OXYCODONE-ACETAMINOPHEN 215 148 S2 29 49
KLOR-CON M20 208 136 30 44
PROPAFENONE HCL 196 187 31 420
HYDRALAZINE HCL 184 162 32 92
AMOXICILLIN 182 148 33 118
AMIODARONE HCL 171 135 34 158
EFFIENT 169 84 35 439
PANTOPRAZOLE SODIUM 166 145 36 22
SERTRALINE HCL 159 146 37 20
DONEPEZIL HCL 155 145 38 21
TRAMADOL HCL 155 117 38 25
NEXIUM 153 83 40 33
HYDROCHLOROTHIAZIDE 153 140 40 11
FLUTICASONE PROPIONATE 146 132 42 46
ZOLPIDEM TARTRATE 141 93 43 24
ALENDRONATE SODIUM 140 133 44 28
NITROSTAT 138 112 45 164
TAMSULOSIN HCL 138 122 45 29
ALLOPURINOL 132 117 47 31
PAROXETINE HCL 131 118 48 66
ETODOLAC 130 92 49 282
BUSPIRONE HCL 125 56 50 146
NAPROXEN 124 88 51 108
GEMFIBROZIL 118 78 52 133
CRESTOR 115 88 53 30
DILTIAZEM 24HR ER 112 101 54 76
LOSARTAN-HYDROCHLOROTHIAZIDE 109 107 55 64
GLIMEPIRIDE 109 78 55 45
RANITIDINE HCL 105 71 57 43
PREDNISONE 104 92 58 37
PROAIR HFA 104 61 58 86
PROPRANOLOL HCL 104 92 58 132
DIGOXIN 103 92 61 35
SPIRONOLACTONE 102 88 62 65
DIOVAN 98 86 63 23
JANUVIA 98 84 63 50
TRAZODONE HCL 96 38 65 53
CELEBREX 96 61 65 71
MIDODRINE HCL 95 83 67 357
CIPROFLOXACIN HCL 93 77 68 72
AMITRIPTYLINE HCL 93 76 R 68 117
CYCLOBENZAPRINE HCL 92 75 R 70 109
NAMENDA 89 87 71 36
CLONIDINE HCL 89 59 71 70
AZITHROMYCIN 89 72 71 39
ADVAIR DISKUS 86 66 74 34
VENLAFAXINE HCL 85 56 75 252
TRIAMCINOLONE ACETONIDE 84 71 76 137
CARBIDOPA-LEVODOPA 83 59 77 85
FENOFIBRATE 80 63 78 94
BUMETANIDE 80 67 78 91
RANEXA 79 66 80 272
MECLIZINE HCL 78 68 81 103
SINGULAIR 77 58 82 100
DIPYRIDAMOLE 75 55 R 83 511
DILTIAZEM 24HR CD 75 73 83 83
POLYETHYLENE GLYCOL 3350 73 68 85 54
ROPINIROLE HCL 73 70 85 124
METOCLOPRAMIDE HCL 72 30 87 168
SYNTHROID 72 70 87 40
MELOXICAM 67 45 89 68
IBUPROFEN 67 43 89 75
RISPERIDONE 67 58 89 61
FINASTERIDE 66 54 92 80
NASONEX 66 39 92 209
TRILIPIX 65 32 94 214
THEOPHYLLINE ANHYDROUS 62 24 95 231
INSULIN SYRINGE 62 40 95 102
GLYBURIDE 61 52 R 97 62
LANSOPRAZOLE 60 52 98 162
METOLAZONE 60 48 98 173
OXYBUTYNIN CHLORIDE 59 41 100 169
CYMBALTA 57 32 101 74
LEVOFLOXACIN 57 44 101 106
NYSTATIN 55 51 103 172
OXYCODONE HCL 54 35 S2 104 67
SUCRALFATE 54 34 104 248
LOVAZA 53 38 106 113
CEFUROXIME 52 46 107 193
TRICOR 51 39 108 96
ENALAPRIL MALEATE 51 37 108 58
FELODIPINE ER 50 50 110 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.